Home > Insider Trading > Filing (0001415889-24-010609)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1991792	Cg Oncology Inc.	CGON	()	4/A

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1487815	Xiangmin Cui	C/O Decheng Capital 3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025	No	No	Yes	No
1834150	Decheng Capital Global Life Sciences Fund Iv, L.p.	3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025	No	No	No	No
1843384	Decheng Capital Management Iv (Cayman), Llc	3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025	No	No	Yes	No
1949026	Decheng Capital Global Healthcare Fund (Master), Lp	3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025	No	No	Yes	No
1949027	Decheng Capital Global Healthcare Gp, Llc	3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-01-29	400,000	$19.00	4,958,810	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. ("Fund IV"). Decheng Capital Management IV (Cayman), LLC ("GP IV") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.